Zhangzhou Pientzehuang Pharmaceutical | 600436 - Cash And Equivalent

Stock Price
150.60
Daily Change
-0.43 -0.28%
Monthly
-4.15%
Yearly
-26.46%
Q2 Forecast
147.47

Zz Pientze Pharmaceu reported CNY1.77B in Cash and Equivalent for its fiscal quarter ending in June of 2025.





Cash And Equivalent Change Date
Akebia Therapeutics USD 184.84M 18.4M Dec/2025
Alaunos Therapeutics USD 1.94M 941K Sep/2025
Avita Medical AUD 10.24M 1.98M Dec/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Dianthus Therapeutics USD 51.09M 4.9M Dec/2025
Ionis Pharmaceuticals USD 2.68B 437M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Jiangsu Hengrui CNY 40.36B 4.24B Sep/2025
Kangmei Pharma CNY 1.18B 278M Sep/2025
Moderna USD 2.6B 1.46B Dec/2025
Revvity USD 919.86M 11.53M Dec/2025
Sh Fosun Pharma CNY 11.48B 1.48B Sep/2025
Tectonic Therapeutic USD 253.8M 14.64M Dec/2025
Viatris USD 1.32B 347.1M Dec/2025
Wuxi Apptec CNY 29.44B 7.95B Sep/2025
Xeris Pharmaceuticals USD 111.04M 19.44M Dec/2025
Zz Pientze Pharmaceu CNY 1.77B 376.03M Jun/2025